• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰腺癌患者中循环肿瘤细胞上皮-间质转化特性的空间异质性与远处复发相关。

Spatial heterogeneity in epithelial to mesenchymal transition properties of circulating tumor cells associated with distant recurrence in pancreatic cancer patients.

作者信息

Dong Xiu, Ma Yongsu, Zhao Xudong, Tian Xiaodong, Sun Yulin, Yang Yinmo, Zhao Xiaohang

机构信息

State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.

Department of General Surgery, Peking University First Hospital, Beijing, China.

出版信息

Ann Transl Med. 2020 Jun;8(11):676. doi: 10.21037/atm-20-782.

DOI:10.21037/atm-20-782
PMID:32617296
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7327339/
Abstract

BACKGROUND

The spatial heterogeneity of epithelial to mesenchymal transition (EMT)-related circulating tumor cells (CTCs) within the circulatory system and its potential clinical relevance remain unclear in pancreatic cancer (PC) patients. We aimed to map the distribution of EMT-related CTCs along the spreading pathway and investigate the prognostic significance due to the potential spatial heterogeneity in the count and phenotypic properties of CTCs.

METHODS

Both portal vein (PoV) and peripheral vein (PV) blood samples were collected from 39 PC patients. CTCs were isolated by using a CD45 negative enrichment method, and EMT-related phenotypes in CTCs were analyzed by 4-channel immunofluorescence. The correlations of CTCs with patient characteristics and recurrence-free survival (RFS) were analyzed.

RESULTS

Both the number {median CTC total count, 10 [6-16] in PoV 5 [1-7] in PV per mL, P<0.0001} and EMT status of CTCs [median mesenchymal CTC (M-CTC) percentage, 0.33 (0.13-0.52) in PoV 0.2 (0-0.4) in PV, P=0.0211] showed significant spatial heterogeneity during dissemination from the PoV to the PV. Univariate analysis adjusting for patient age and sex revealed that CTC total count and M-CTC percentage in PoV samples could be risk factors for RFS in PC patients (P=0.003 and P=0.001, respectively), and ROC curve analysis found that both of these factors had good performance in distinguishing patients with early distant recurrence (within 6 months), with the optimal cut-off values of 14 cells/mL (AUROC =0.893, sensitivity =0.857, specificity =0.813, P=0.001) and 0.545 (AUROC =0.795, sensitivity =0.714, specificity =0.906, P=0.016), respectively.

CONCLUSIONS

Multivascular assessment of EMT-related CTCs suggested profound dynamic alterations in total count and phenotypes during dissemination, and the spatial heterogeneity of CTCs in circulation could help establish novel prognosis markers in PC patients.

摘要

背景

在胰腺癌(PC)患者中,循环系统内上皮-间质转化(EMT)相关循环肿瘤细胞(CTC)的空间异质性及其潜在的临床相关性仍不清楚。我们旨在描绘EMT相关CTC沿扩散途径的分布,并研究由于CTC数量和表型特性的潜在空间异质性而产生的预后意义。

方法

从39例PC患者中采集门静脉(PoV)和外周静脉(PV)血样。采用CD45阴性富集法分离CTC,并通过4通道免疫荧光分析CTC中的EMT相关表型。分析CTC与患者特征及无复发生存期(RFS)的相关性。

结果

CTC的数量{中位数CTC总数,PoV中每毫升为10[6-16]个,PV中为5[1-7]个,P<0.0001}和EMT状态[中位数间充质CTC(M-CTC)百分比,PoV中为0.33(0.13-0.52),PV中为0.2(0-0.4),P=0.0211]在从PoV扩散到PV的过程中均显示出显著的空间异质性。对患者年龄和性别进行校正的单因素分析显示,PoV样本中的CTC总数和M-CTC百分比可能是PC患者RFS的危险因素(分别为P=0.003和P=0.001),ROC曲线分析发现这两个因素在区分早期远处复发(6个月内)患者方面均具有良好的性能,最佳截断值分别为14个细胞/毫升(AUROC=0.893,敏感性=0.857,特异性=0.813,P=0.001)和0.545(AUROC=0.795,敏感性=0.714,特异性=0.906,P=0.016)。

结论

对EMT相关CTC的多血管评估表明,在扩散过程中总数和表型存在深刻的动态变化,循环中CTC 的空间异质性有助于建立PC患者的新预后标志物。

相似文献

1
Spatial heterogeneity in epithelial to mesenchymal transition properties of circulating tumor cells associated with distant recurrence in pancreatic cancer patients.胰腺癌患者中循环肿瘤细胞上皮-间质转化特性的空间异质性与远处复发相关。
Ann Transl Med. 2020 Jun;8(11):676. doi: 10.21037/atm-20-782.
2
Circulating Tumor Cells from Different Vascular Sites Exhibit Spatial Heterogeneity in Epithelial and Mesenchymal Composition and Distinct Clinical Significance in Hepatocellular Carcinoma.来自不同血管部位的循环肿瘤细胞在上皮和间充质组成上表现出空间异质性,并且在肝细胞癌中具有不同的临床意义。
Clin Cancer Res. 2018 Feb 1;24(3):547-559. doi: 10.1158/1078-0432.CCR-17-1063. Epub 2017 Oct 25.
3
Portal Venous Circulating Tumor Cells Undergoing Epithelial-Mesenchymal Transition Exhibit Distinct Clinical Significance in Pancreatic Ductal Adenocarcinoma.经历上皮-间质转化的门静脉循环肿瘤细胞在胰腺导管腺癌中具有独特的临床意义。
Front Oncol. 2021 Oct 28;11:757307. doi: 10.3389/fonc.2021.757307. eCollection 2021.
4
The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer.基于上皮-间充质转化标志物的循环肿瘤细胞表型检测在 HER2 阴性转移性乳腺癌一线化疗中的预后和治疗意义。
Cancer Commun (Lond). 2019 Jan 3;39(1):1. doi: 10.1186/s40880-018-0346-4.
5
Endoscopic Ultrasound-Guided Acquisition of Portal Venous Circulating Tumor Cells as a Potential Diagnostic and Prognostic Tool for Pancreatic Cancer.内镜超声引导下获取门静脉循环肿瘤细胞作为胰腺癌潜在的诊断和预后工具
Cancer Manag Res. 2021 Oct 5;13:7649-7661. doi: 10.2147/CMAR.S330473. eCollection 2021.
6
Molecular characterization of circulating tumor cells in pancreatic ductal adenocarcinoma: potential diagnostic and prognostic significance in clinical practice.胰腺导管腺癌循环肿瘤细胞的分子特征:临床实践中的潜在诊断和预后意义。
Hepatobiliary Surg Nutr. 2021 Dec;10(6):796-810. doi: 10.21037/hbsn-20-383.
7
Clinical Significance of Mesenchymal Circulating Tumor Cells in Patients With Oligometastatic Hormone-Sensitive Prostate Cancer Who Underwent Cytoreductive Radical Prostatectomy.接受减瘤性根治性前列腺切除术的寡转移激素敏感性前列腺癌患者间充质循环肿瘤细胞的临床意义
Front Oncol. 2022 Jan 20;11:812549. doi: 10.3389/fonc.2021.812549. eCollection 2021.
8
Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practice.循环肿瘤细胞中上皮-间充质转化标志物的分子检测:在临床实践中的潜在作用。
World J Gastroenterol. 2019 Jan 7;25(1):138-150. doi: 10.3748/wjg.v25.i1.138.
9
Circulating Tumor Cell Phenotype Indicates Poor Survival and Recurrence After Surgery for Hepatocellular Carcinoma.循环肿瘤细胞表型预示着肝癌手术后生存和复发不良。
Dig Dis Sci. 2018 Sep;63(9):2373-2380. doi: 10.1007/s10620-018-5124-2. Epub 2018 Jun 21.
10
Circulating tumor cell associated white blood cell cluster as a biomarker for metastasis and recurrence in hepatocellular carcinoma.循环肿瘤细胞相关白细胞簇作为肝细胞癌转移和复发的生物标志物
Front Oncol. 2022 Nov 17;12:931140. doi: 10.3389/fonc.2022.931140. eCollection 2022.

引用本文的文献

1
Unveiling the dynamics of circulating tumor cells in colorectal cancer: from biology to clinical applications.揭示结直肠癌中循环肿瘤细胞的动态变化:从生物学到临床应用
Front Cell Dev Biol. 2024 Oct 30;12:1498032. doi: 10.3389/fcell.2024.1498032. eCollection 2024.
2
Single-cell and spatial omics unravel the spatiotemporal biology of tumour border invasion and haematogenous metastasis.单细胞和空间组学揭示了肿瘤边界浸润和血源性转移的时空生物学。
Clin Transl Med. 2024 Oct;14(10):e70036. doi: 10.1002/ctm2.70036.
3
Phenotypic characteristics of circulating tumor cells and predictive impact for efficacy of chemotherapy in patients with pancreatic cancer: a prospective study.

本文引用的文献

1
Patterns of Recurrence After Resection of Pancreatic Ductal Adenocarcinoma: A Secondary Analysis of the ESPAC-4 Randomized Adjuvant Chemotherapy Trial.胰腺导管腺癌切除术后复发模式:ESPAC-4 随机辅助化疗试验的二次分析。
JAMA Surg. 2019 Nov 1;154(11):1038-1048. doi: 10.1001/jamasurg.2019.3337.
2
Tumor-proximal liquid biopsy to improve diagnostic and prognostic performances of circulating tumor cells.肿瘤近端液活检提高循环肿瘤细胞的诊断和预后性能。
Mol Oncol. 2019 Sep;13(9):1811-1826. doi: 10.1002/1878-0261.12534. Epub 2019 Jul 25.
3
Inferring the Evolution and Progression of Small-Cell Lung Cancer by Single-Cell Sequencing of Circulating Tumor Cells.
循环肿瘤细胞的表型特征及其对胰腺癌患者化疗疗效的预测作用:一项前瞻性研究
Front Oncol. 2023 Sep 1;13:1206565. doi: 10.3389/fonc.2023.1206565. eCollection 2023.
4
Tumor-derived proliferative CTCs and CTC clusters predict aggressiveness and early recurrence in hepatocellular carcinoma patients.肿瘤来源的增殖性循环肿瘤细胞和循环肿瘤细胞簇可预测肝癌患者的侵袭性和早期复发。
Cancer Med. 2023 Jul;12(13):13912-13927. doi: 10.1002/cam4.5946. Epub 2023 Jun 19.
5
Circulating tumour cells in gastrointestinal cancers: food for thought?消化道肿瘤循环肿瘤细胞:值得深思?
Br J Cancer. 2023 Jun;128(11):1981-1990. doi: 10.1038/s41416-023-02228-8. Epub 2023 Mar 17.
6
The mesenchymal circulating tumor cells as biomarker for prognosis prediction and supervision in hepatocellular carcinoma.间质循环肿瘤细胞作为肝细胞癌预后预测和监测的生物标志物。
J Cancer Res Clin Oncol. 2023 Aug;149(9):6035-6048. doi: 10.1007/s00432-022-04526-9. Epub 2023 Jan 12.
7
The clinical significance of circulating tumor cells and T lymphocyte subtypes in pancreatic cancer patients.循环肿瘤细胞和 T 淋巴细胞亚群在胰腺癌患者中的临床意义。
Bioengineered. 2022 Feb;13(2):2130-2138. doi: 10.1080/21655979.2021.2023800.
8
Circulating tumor cells: biology and clinical significance.循环肿瘤细胞:生物学和临床意义。
Signal Transduct Target Ther. 2021 Nov 22;6(1):404. doi: 10.1038/s41392-021-00817-8.
9
Portal Venous Circulating Tumor Cells Undergoing Epithelial-Mesenchymal Transition Exhibit Distinct Clinical Significance in Pancreatic Ductal Adenocarcinoma.经历上皮-间质转化的门静脉循环肿瘤细胞在胰腺导管腺癌中具有独特的临床意义。
Front Oncol. 2021 Oct 28;11:757307. doi: 10.3389/fonc.2021.757307. eCollection 2021.
10
Epithelial to Mesenchymal Transition: A Challenging Playground for Translational Research. Current Models and Focus on Relevance and Gastrointestinal Cancers.上皮间质转化:转化研究的富有挑战性的领域。当前模型及对相关性和胃肠道癌的关注。
Int J Mol Sci. 2021 Oct 25;22(21):11469. doi: 10.3390/ijms222111469.
通过循环肿瘤细胞的单细胞测序推断小细胞肺癌的演进和进展。
Clin Cancer Res. 2019 Aug 15;25(16):5049-5060. doi: 10.1158/1078-0432.CCR-18-3571. Epub 2019 May 21.
4
Vimentin-positive circulating tumor cells as a biomarker for diagnosis and treatment monitoring in patients with pancreatic cancer.波形蛋白阳性循环肿瘤细胞作为胰腺癌诊断和治疗监测的生物标志物。
Cancer Lett. 2019 Jun 28;452:237-243. doi: 10.1016/j.canlet.2019.03.009. Epub 2019 Mar 21.
5
Pancreatic Adenocarcinoma, Version 1.2019.胰腺导管腺癌临床实践指南(2019 年版)
J Natl Compr Canc Netw. 2019 Mar 1;17(3):202-210. doi: 10.6004/jnccn.2019.0014.
6
Primarily resectable pancreatic adenocarcinoma - to operate or to refer the patient to an oncologist?主要可切除的胰腺腺癌 - 是手术还是将患者转介给肿瘤学家?
Crit Rev Oncol Hematol. 2019 Mar;135:95-102. doi: 10.1016/j.critrevonc.2019.01.010. Epub 2019 Jan 25.
7
Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practice.循环肿瘤细胞中上皮-间充质转化标志物的分子检测:在临床实践中的潜在作用。
World J Gastroenterol. 2019 Jan 7;25(1):138-150. doi: 10.3748/wjg.v25.i1.138.
8
Cancer statistics, 2019.癌症统计数据,2019 年。
CA Cancer J Clin. 2019 Jan;69(1):7-34. doi: 10.3322/caac.21551. Epub 2019 Jan 8.
9
Fractional uptake of circulating tumor cells into liver-lung compartments during curative resection of periampullary cancer.壶腹周围癌根治性切除术中循环肿瘤细胞向肝肺转移灶的摄取分数
Oncol Lett. 2018 Nov;16(5):6331-6338. doi: 10.3892/ol.2018.9435. Epub 2018 Sep 12.
10
Implications of the Pattern of Disease Recurrence on Survival Following Pancreatectomy for Pancreatic Ductal Adenocarcinoma.胰导管腺癌行胰腺切除术治疗后疾病复发模式对生存的影响。
Ann Surg Oncol. 2018 Aug;25(8):2475-2483. doi: 10.1245/s10434-018-6558-7. Epub 2018 Jun 14.